Ectin Research AB
Pharmaceutical company developing novel oncology treatments, with a lead drug in trials.
ECTIN B | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0015987706 (+1 more)
- LEI:
- 549300IDDKUG9RWXFN04
- Country:
- Sweden
- Address:
- c/o Walthon Advokater, 102 43 Stockholm
- Website:
- https://www.ectinresearch.com/
Description
Ectin Research AB is a pharmaceutical development company focused on oncology. The company's core activity is the research and development of novel treatments designed to eliminate cancerous tumors. Its lead drug candidate, MFA-370, is a combination therapy developed to treat various forms of cancer. The therapy is undergoing clinical trials, with an initial focus on indications such as metastatic bladder cancer. The company's strategy centers on advancing its therapeutic projects through clinical development towards commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ectin Research AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ectin Research AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ectin Research AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
